Introduction: Shortness of breath is a common presenting symptom to the emergency department (ED) that can arise from a myriad of possible diagnoses. Asthma is one of the major causes.
72 hour periods in May, August and October 2014. Primary outcomes were patient epidemiology, clinical features, treatment and outcomes (hospital length of stay (LOS) and mortality).
Results:
Of the 3044 patients with dyspnea, 387 (12.7%) patients had an ED diagnosis of asthma. The median age was 45 years, 60.1% were female, 16.1% were active or recent smokers and 30.4% arrived by ambulance. Inhaled bronchodilator therapy was initiated in 88.1% of patients, and 66.9% received both inhaled bronchodilators and systemic corticosteroids. After treatment in the ED, 65.4% were discharged. No death was reported.
Conclusion: Asthma is common among patients presenting with a principal symptom of dyspnea in the ED of the Asia Pacific region. There was a suboptimal adherence to international guidelines on investigations and treatments of acute asthma exacerbations presenting an opportunity to improve the efficiency of care.
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| IN TRO DUCT IO N
Shortness of breath is a common presenting symptom to the emergency department (ED) that can arise from a myriad of possible diagnoses. 1 Major etiological groups are cardiac and respiratory disease; among the latter, asthma is one of the major causes. The World Health Organization estimates that over 235 million people suffer from asthma globally. 2 There is large variability in the prevalence of asthma among countries worldwide; the highest being over 20% reported in Australia. 3, 4 Morbidity, mortality and the number of disability-adjusted life years lost due to asthma are substantial, particularly in lower income nations. 5, 6 The incidence of asthma exacerbations varies with seasons, environmental conditions and air pollutants. [7] [8] [9] Frequent attendances to the ED by asthmatic patients have been associated with higher mortality. 10, 11 National and international guidelines recommend a number of treatments to optimize outcomes. [12] [13] [14] These include inhaled bronchodilators, systemic corticosteroids and targeted oxygen therapy. There is limited information on the epidemiology of asthma in the Asia Pacific region and about compliance with guideline recommended therapies. The objective of this planned sub-study is to describe the demographics, clinical characteristics, treatment and patient outcomes of the cohort of patients who attended the ED in the Asia Pacific region with a primary symptom of dyspnea and have a subsequent ED diagnosis of asthma.
| MAT ERI AL S A ND M ETH ODS
The methodology of this study has been published previously. 15 Briefly, the Asia, Australia and New Zealand This planned sub-study includes patients in the AANZ-DEM study with an ED diagnosis of asthma. The primary outcomes of interest are the epidemiology, investigations ordered, treatments given and overall outcomes of these patients. Secondary outcomes consist of geographical variations of the primary outcomes and adherence to international guidelines on asthma management. Guidelines for the initial assessment of severity of acute asthma exacerbations in adults include evaluation of symptoms, vital signs, measurement of peak expiratory flow rate and indications for blood gas and chest radiograph. Guidelines for the treatment of acute asthma encompasses indications for the provision of supplemental oxygen, steroid therapy, beta2-agonist bronchodilators, ipratropium bromide, other forms of adjunctive therapy such as intravenous magnesium sulfate and prescription of antibiotics.
Analysis was largely by descriptive statistics. Comparisons of proportions and measures of associations were done using the Chi-square or Fisher's exact test, where appropriate. Nonparametric data were compared using the Mann-Whitney U test. Data analyses were performed with IBM SPSS Statistics for Windows, Version 22.0 (IBM Corp., Armonk, New York) and Analyse-it for Microsoft Excel, Version 2.20 (Analyse-it Software, Ltd., Leeds, UK). This analysis used data which was collected for studies about patients presenting to ED with dyspnea. Hence, a priori sample size calculations were not necessary. There may have been situations where the same patient presented more than once and these were not de-duplicated. However, given the large sample sizes of the groups, this matter would be expected to have minimal impact on the results presented or the outcomes of the analyses performed. Reporting of results complies with the STROBE guidelines. 16 It should be noted that only specific statistical tests (and hence P values) were performed and reported, in order to avoid inflating Type 1 error. Human research ethics approvals were obtained for all sites according to local requirements. Most jurisdictions did not require patient consent for data collection. Some sites in Queensland required patient consent so that part of the data is not consecutive.
| RES UL TS

| Characteristics of study subjects
Forty-six EDs contributed data on 3044 patients with dyspnea as a presenting symptom. Thirty-three sites were in Australia, four sites were in New Zealand, four sites were in Hong Kong, three sites were in Singapore and two sites were in Malaysia.
In 2014, the study sites had a combined annual ED census of 2 886 178 patients (see Acknowledgements for full list). Three hundred eighty-seven patients had an ED diagnosis of asthma [12.7%; 95% confidence interval (CI) 11.6%-14.0%]. Asthma cases contributed to 0.64% (387/60 059) of all ED attendances in the study periods. There was a higher incidence of asthma exacerbations among dyspneic patients in the EDs of Asian countries (171/1086, 15.7%; 95% CI 13.7%-18.1%) compared to Australia and New Zealand (216/ 1958, 11.0%; 95% CI 9.7%-12.5%).
Over 75% of patients were younger than 60 years (Table 1 ). There was a greater proportion of female patients with asthma in the EDs of Australia and New Zealand (ANZ) compared to South East Asia (SEA) (65.3% vs 53.2%). The overall smoking prevalence was 16.1%, again a much higher preponderance in ANZ compared to SEA (22.1% vs 8.8%). Over 90% of patients were previously diagnosed with asthma, and 6% had a concomitant history of chronic obstructive pulmonary disease. Just under one-third (30.4%) arrived to the ED by ambulance, many more in ANZ than in SEA (37.3% vs 21.7%).
| Medications
Common pre-existing prescribed asthma medications are also described in Table 1 and included inhaled betasympathomimetics (74.9%), inhaled corticosteroids (46.0%), inhaled anticholinergics (14.7%) and oral corticosteroids (13.5%). There were more patients who were on inhaled anticholinergics (16.4% vs 8.2%), inhaled corticosteroids (52.3% vs 38.0%) and oral corticosteroids (17.4% vs 8.8%) in ANZ versus SEA.
| Clinical features
Clinical features including physical examination findings are shown in Table 2 . The majority of patients experienced between 1 and 4 days of shortness of breath before presenting to the ED. A small proportion (6.1%) had documented fever. There were 18.7% who had more severe symptoms, at best being able to only speak in phrases. Over 10% experienced severe tachypnea (respiratory rate 30 breaths per minute). More than 80% were found to have wheeze or rhonchi during examination.
| Investigations
Chest radiographs were obtained in 70.4% of patients, and 23.5% had blood gas analysis (Table 2 ).
| Treatment
More than 70% did not receive any form of initial oxygen therapy in the ED (Table 3) . Only one patient received noninvasive ventilation and none required endotracheal intubation. Over 88% received inhaled bronchodilator therapy and a lower proportion (69.7%) received systemic corticosteroids. Two-thirds of patients received both inhaled bronchodilators and systemic corticosteroids. More patients were prescribed antibiotics for their asthma exacerbation in ANZ compared to SEA (30.5% vs 14.0%).
| Outcomes
Almost two-thirds were discharged from the ED, including those who were managed in an ED observation unit (Table 3) . Eleven (2.8%) patients required admission to the intensive care unit and there were no deaths reported in our cohort. Among those who required admission to the hospital wards, the median length of stay was 4 days (interquartile range 3-6 days). Of those patients admitted to hospital with asthma, asthma was confirmed as the final primary diagnosis in 84% with lower respiratory tract infection (9%) and chronic obstructive pulmonary disease (7%) being the alternative primary diagnoses.
| DI S CU S S I ON
Our study shows that asthma is a relatively common diagnosis encountered in adult patients presenting with dyspnea to KUAN ET AL. | the ED in the Asia Pacific region, accounting for a higher proportion of cases in SEA compared to ANZ. We also found that compliance with guideline recommended investigations and treatments were suboptimal, from high utilization of chest radiographs and blood gas analyses, and increased proportion of inhaled ipratropium bromide administration and prescription of antibiotics, respectively. The results of this study could be a useful baseline reference for which future ED studies on asthma in the region could be based upon after education and promulgation of management guidelines and recommendations. [12] [13] [14] Over the last 25 years, the epidemiology of asthma exacerbations has changed to one of the decline in hospitalization rates postulated to be due to increased use of asthma control medications, lower tendency for clinicians to admit patients and administrative incentives in certain countries to reduce hospital admission. 17 However, the disposition of patients presenting to the ED in our study is somewhat dissimilar to those previously published in North America. 18 The proportion of patients admitted to the hospital ward was much higher in our cohort (31.5% vs 7.0%). 18 We surmise that the reasons could include higher severity of asthma exacerbations in the region. Our rationale for this is the high proportion of patients who arrived to the ED by ambulance (30.4%) ( therapy is recommended to maintain saturation at 93%-95%. The majority of patients in our cohort (70.8%) did not receive any supplemental oxygen and only a small proportion received untitrated supplemental oxygen via face mask (11.9%) and nonrebreather mask (1.8%). We were unable to determine whether the target oxygen saturations were met due to lack of data collected after initiation of oxygen therapy. Inhaled short-acting beta2-agonists and systemic corticosteroids are both mainstays of management for acute asthma exacerbations. Furthermore, there is strong evidence that systemic corticosteroids hasten the resolution of exacerbations and prevent relapses. 19 In spite of this, a less than optimal 66.8% of patients received both forms of therapy in our study, suggesting room for improvement in efficiency of asthma care with regard to compliance to guidelines. Slightly over half (55.8%) of patients with asthma exacerbations in this study received inhaled anticholinergic therapy during their ED visit. Current guidelines by the Expert Panel of the National Asthma Education and Prevention Program Pulse rate 120, n (%; 95% CI) 53 (13.9; 10.7-17.9)
Respiratory rate (breaths per minute), median ( | recommend inhaled ipratropium be used for patients with severe exacerbations in the ED. 20 We were unable to collect data on structured severity assessment as different sites used different methods, but if the admission rate of approximately 30% is taken as a proxy for more severe disease, it would appear that there was a disproportionately higher use of inhaled anticholinergics for the milder forms of asthma exacerbations in our cohort. Chest radiographs and blood gas measurements are not routinely recommended for adults with asthma exacerbations unless patients are not responding to initial therapy or are deteriorating. 12, 14 In our study, 70.4% of patients had a chest radiograph done. Previous studies reported only about 2% abnormal findings from chest radiographs among acute asthmatics in the ED. 21, 22 Similarly, 23.5% of patients had blood gas analysis, but only 2.8% were eventually admitted to the intensive care unit. Reasons for the overuse of chest radiographs are unclear but may represent habit or a lack of awareness of the evidence and guideline recommendations. We reported data on blood gas analysis but did not differentiate between arterial and venous analyses. It is possible that clinicians used a venous blood gas analysis to screen for hypercarbia in patients where there was clinical concern of severe disease. Many factors can trigger an asthma exacerbation. Most respiratory infections that trigger the exacerbation are viral in origin. Hence, routine use of empiric antibiotic therapy is not recommended. 12, 14, 24, 25 Despite this, there was a high proportion (23.2%) of antibiotic usage in our study, even though symptoms and signs of bacterial infection were lacking. Inappropriate use of antibiotics has driven the rapid increase in antibiotic resistance and compounded by the dearth of new antibiotics in the pipeline, a postantibiotic era is looming. 26 While lack of knowledge may be a contributor to failures to comply with guideline-recommended investigation and treatment, it is more likely that the major reason is human error with contributing factors such as time constraints in ED, distraction and competing patient priorities as several patients are being processed by a doctor at any given time, imperfect memory and cognitive overload. High staff turnover makes it difficult to ensure that all staff are educated in clinical rationale for investigation and treatment and guideline recommendations for all conditions encountered in the ED. One approach suggested to address deficits in care provided includes the introduction of an asthma proforma or checklist. An alternative approach would be the use of clinical informatics systems such as computer-assisted decision support, which has been proven to improve patient safety and has been recommended by the US Agency for Healthcare Research and Quality. 27 This can range from simple reminder systems to monitor-based color-coded guideline compliance visual alerts. Our study has several limitations that should be considered when interpreting our results. First, the results may not be generalizable to other regions outside of South East Asia and Australasia as health care access and affordability, particularly to the ED, may differ. Second, asthma as a diagnosis was based on the treating ED clinician's judgment. Although potentially subject to error in part related to incomplete information and investigations, this represents the 'real world' practice in EDs. Determination of patients who required guideline recommendations in the management of their acute asthma exacerbations were not individually detailed, which could have blunted the ascertainment of compliance to guidelines. Third, the severities of asthma exacerbations were not explicitly measured. Helpful information on asthma phenotype through information on history of chronicity, differentiation between short-and long-acting bronchodilator use, utilization of combination treatment of inhaled corticosteroids and long-acting bronchodilators and frequency of exacerbations were not collected. It would have been useful to have had information on other investigations and treatment modalities, such as peak flow measurements and spirometry, but these are inconsistently performed in ED. 28 We did not have data on intravenous administration of magnesium sulfate to better assess compliance to international guidelines for patients with severe asthma.
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| CO NCL US I ONS
In conclusion, this study on patients with asthma provides a unique understanding of regional variation in demographics, investigations and treatment in a cohort of patients from EDs in the Asia Pacific region. There was seemingly suboptimal adherence to international guidelines on investigations and treatments, which alerts us to an opportunity to improve efficiency of care.
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